Atorvastatin / ezetimibe Side Effects
The more commonly reported adverse reactions have included increased ALT, increased AST, and musculoskeletal pain.[Ref]
Common (1% to 10%): ALT increased (5%), AST increased (4%)
Common (1% to 10%): Musculoskeletal pain (3.8 to 4%), arthralgia (3 to 6.9%), pain in extremity (2.7 to 6%), myalgia (3.5%), muscle spasms (3%), muscle weakness (2%)
Postmarketing reports: Myopathy/rhabdomyolysis, necrotizing myopathy (rarely), injury, poisoning and procedural complication, tendon rupture, myositis[Ref]
Common (1% to 10%): Hot flushes (2%)[Ref]
Common (1% to 10%): Urinary tract infection (5.7%)[Ref]
Common (1% to 10%): Coughing (2 to 3%), bronchitis (2%), sinusitis (2 to 2.8%), upper respiratory tract infection (4.3%), nasopharyngitis (up to 8.3%), pharyngolaryngeal pain (up to 2.3%)
Postmarketing reports: Interstitial lung disease[Ref]
Postmarketing reports: Fatigue
Medically reviewed by Drugs.com. Last updated on Jul 27, 2021.
More about atorvastatin / ezetimibe
- Other brands
Related treatment guides
1. Cerner Multum, Inc. "Australian Product Information." O 0
2. "Product Information. Liptruzet (atorvastatin-ezetimibe)." Merck & Company Inc, Whitehouse Station, NJ.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.